NCBiotech News

News of the first U.S. coronavirus case hit the American public on Tuesday, Jan. 21. For Jessilyn Dunn, PhD, assistant professor in the Departments of Biomedical Engineering and Biostatistics and Bioinformatics at Duke University and director of the Duke BIG IDEAs Lab, the infection in Washington State was a cue to launch a new study⁠—CovIdentify.

RTP's APIE Therapeutics has signed a licensing agreement with RTI International to develop a class of RTI-developed compounds targeting heart failure and lung disease.

Durham based BioAgilytix Labs has partnered with Boston’s Brio Systems to launch a platform to provide U.S. employers comprehensive COVID-19 testing programs.

Durham's Pairwise uses its gene editing technology to harness nutrient-rich, pest-resistant qualities of the leafy green Brassica juncea while diminishing pungent flavor.

Durham's IMMvention Therapeutix, which discovers and develops therapies that inhibit inflammation, was one of three finalists in LaunchBio’s Big Pitch competition for the most promising life science or biotech startup in the United States.

Durham-based Dualogics has sold its core technology for producing therapeutic antibodies to a Canadian biotechnology company.

Merz Therapeutics, with North American headquarters in Raleigh, has gained a new use for Xeomin, its botulinum toxin therapy.

Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the 100 most inspiring leaders in the pharmaceutical industry.

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory milestone for its potential therapy for small cell lung cancer.

T-Line Hernia Mesh, the newest medical advance from Deep Blue Medial Advances, has just received U.S. Food and Drug Administration marketing clearance. 

UPL, a multinational agriculture company based in India, has opened a global research-and-development hub in Research Triangle Park to develop products for sustainable agriculture in partnership with collaborating companies.

Eva Garland Consulting, LLC (EGC) is one of the country’s fastest-growing private businesses – for a third year in a row – as other NC life sciences companies also made the list, according to Inc. magazine.

Federal health officials have tapped RTI International to join a collaboration tracking COVID-19’s ability to cause severe illness and the effectiveness of proposed treatments.

A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell therapy startups with plans to build an $83 million biomanufacturing facility in Durham that could employ more than 200 people over five years.

The Dole Food Company has entered a five-year strategic partnership with the young RTP-based ag tech company Elo Life Systems to keep bananas alive and available, because Elo's gene editing technology is uniquely qualified to develop Fusarium-resistant banana varieties.